Geode Capital Management, LLC Tenaya Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,040,046 shares of TNYA stock, worth $4.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,040,046

Previous 928,763 11.98%

Holding current value

$4.38 Million

Previous $3.01 Million 80.76%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.88 - $6.8 $320,495 - $756,724	111,283 Added 11.98%	1,040,046 $5.44 Million
Q4 2023 Feb 13, 2024	BUY	$1.73 - $3.39 $96,101 - $188,314	55,550 Added 6.36%	928,763 $3.01 Million
Q3 2023 Nov 13, 2023	BUY	$2.55 - $5.65 $136,784 - $303,071	53,641 Added 6.55%	873,213 $2.23 Million
Q2 2023 Aug 11, 2023	BUY	$2.64 - $7.64 $75,984 - $219,894	28,782 Added 3.64%	819,572 $4.81 Million
Q1 2023 May 15, 2023	BUY	$1.92 - $3.59 $604,888 - $1.13 Million	315,046 Added 66.22%	790,790 $2.25 Million

Q4 2022 Feb 13, 2023	BUY	$1.68 - $3.19 $43,404 - $82,416	25,836 Added 5.74%	475,744 $956,000
Q3 2022 Nov 14, 2022	BUY	$2.9 - $5.88 $200,874 - $407,289	69,267 Added 18.2%	449,908 $1.3 Million
Q2 2022 Aug 12, 2022	BUY	$5.01 - $14.12 $62,244 - $175,426	12,424 Added 3.37%	380,641 $2.14 Million
Q1 2022 May 13, 2022	BUY	$9.41 - $19.3 $1.31 Million - $2.68 Million	139,078 Added 60.7%	368,217 $4.34 Million
Q4 2021 Feb 11, 2022	BUY	$18.41 - $29.58 $242,570 - $389,746	13,176 Added 6.1%	229,139 $4.34 Million
Q3 2021 Nov 12, 2021	BUY	$15.35 - $26.66 $3.32 Million - $5.76 Million	215,963 New	215,963 $4.46 Million

Others Institutions Holding TNYA

# of Institutions

Shares Held

47.2M

Call Options Held

35.8K

Put Options Held

1.1K

View Full List

About Tenaya Therapeutics, Inc.

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $174M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

More about TNYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Tenaya Therapeutics, Inc. Transaction History